Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

3.95
-0.0300-0.75%
Volume:313.95K
Turnover:1.25M
Market Cap:304.60M
PE:-3.97
High:4.07
Open:4.02
Low:3.94
Close:3.98
Loading ...
Feb 18, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Dec 16, 2019

Major Issues Report

Current report, item 5.02
Dec 09, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 12, 2019

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Nov 08, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Oct 29, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 29, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 07, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 29, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities